GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
November 14, 2024
November 14, 2024
CHICAGO, Illinois, Nov. 14 (TNSres) -- G.E. HealthCare issued the following news release:
* * *
* New MRI technology aims to advance neuroimaging and biomarker research
* * *
GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA MAGNUS,[i] a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential . . .
* * *
* New MRI technology aims to advance neuroimaging and biomarker research
* * *
GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA MAGNUS,[i] a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential . . .